Prescription drug · BLA
Cathflo Activase (alteplase) NDC 50242-041
Alteplase 2.2 mg/2mL · Injection, Powder, Lyophilized, For solution · Intravenous · Genentech, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50242-041-10 | 50242004110 | 10 VIAL in 1 CARTON (50242-041-10) / 2 mL in 1 VIALMarketed from Oct 14, 2019 | |
| 50242-041-64 | 50242004164 | 1 VIAL in 1 CARTON (50242-041-64) / 2 mL in 1 VIALMarketed from Sep 4, 2001 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cathflo Activase
- Generic name (nonproprietary)
- alteplase
- Active ingredients
- Alteplase — 2.2 mg/2mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous
- Labeler
- Genentech, Inc.
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 103172
- Marketing start
- Listing expires
- Identifiers
- Product ID 50242-041_0c2938dd-2978-411f-bd76-208fc8754838SPL ID 0c2938dd-2978-411f-bd76-208fc8754838SPL set ID 91ecdef2-95ff-42dd-a31c-c8a09cab3ad9UNII 1RXS4UE564
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N450242004110followed by a unit qualifier and the quantityPackage 50242-0041-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Cathflo ® Activase ® (Alteplase) is indicated for the restoration of function to central venous access devices as assessed by the ability to withdraw blood.
Excerpt only. Read the full label for complete information.
Other NDCs under BLA 103172
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.